Temporary contraindication to chemotherapy due to toxicity: blinatumomab's effectiveness in paediatric patients with B‐acute lymphoblastic leukaemia
Year: 2023
Type: article
Abstract: Acute lymphoblastic leukaemia's (ALL) prognosis has improved with increased treatment intensity and haematopoietic stem cell transplantation (allo-HSCT). Despite this progress, 2%–3% treatment failed in children after induction. Furthermore, usual treatments such as chemotherapy are associated with high morbidity and mortality: death-related toxicity is similar to death due to relapse.[...]
Source: British Journal of Haematology
DOI: 10.1111/bjh.18759
Institutions: Hôpital Necker-Enfants Malades, Assistance Publique – Hôpitaux de Paris, Lyon 1 Université, Hospices Civils de Lyon, Centre Hospitalier Universitaire de Bordeaux, Centre Hospitalier Universitaire de Reims, Centre Hospitalier Universitaire de Lille, Centre Hospitalier Universitaire de Toulouse, Centre Hospitalier Universitaire de Besançon, Sorbonne Université, Hôpital Armand-Trousseau, Centre Hospitalier Universitaire de Nantes, Hôpital Robert-Debré
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4361007477
